Table 2

Total episodes of anti-vascular endothelial growth factor between 2013 and 2018, by diagnosis and year, Portugal

Diagnosis	Total			2013		2014		2015		2016		2017		2018
Diagnosis	N	%	% cumulative	N	%	N	%	N	%	N	%	N	%	N	%
Neovascular age-related macular degeneration	100 168	33.57	33.57	11 575	37.90	13 415	36.32	16 357	33.60	16 094	28.95	20 857	33.74	2187	33.72
Diabetic macular oedema	85 997	28.82	62.38	6578	21.54	8044	21.78	13 371	27.47	18 181	32.70	19 769	31.98	20 054	30.92
Retinal vein occlusion	18 716	6.27	68.65	1451	4.75	2104	5.70	2841	5.84	3500	6.30	3956	6.40	4864	7.50
Unspecified macular degeneration	16 042	5.38	74.03	1750	5.73	1862	5.04	2712	5.57	3979	7.16	2724	4.41	3015	4.65
Proliferative diabetic retinopathy	15 737	5.27	79.30	1846	6.04	2297	6.22	2726	5.60	2144	3.86	3250	5.26	3474	5.36
Choroidal neovascularisation	13 783	4.62	83.92	1698	5.56	2190	5.93	2619	5.38	3040	5.47	2154	3.48	2082	3.21
Retinal oedema	12 581	4.22	88.14	1256	4.11	1890	5.12	1690	3.47	1677	3.02	2575	4.17	3493	5.38
Other diagnosis	35 405	11.86	100	4388	14.37	5129	13.89	6361	13.07	6979	12.55	6533	10.57	6015	9.27
Total	298 429	100		30 542	100	36 931	100	48 677	100	55 594	100	61 818	100	64 867	100